Skip to main content
Premium Trial:

Request an Annual Quote

Age Labs Gets €1M From Research Council of Norway

NEW YORK (GenomeWeb) – Age Labs, an Oslo-based biomarker discovery company, has been awarded €1 million (about $1.1 million) in R&D funding from the Research Council of Norway to support the development of a unique biomarker for aging.

Specifically, the company is developing a methylated DNA biomarker that will predict all-cause mortality risk and risk of developing certain age-related diseases. The company expects the biomarker to enable pharmaceutical companies to increase the probability of success in clinical trials by providing more accurate risk information about patients participating in the trials.

Age Labs is leading the four-year project, which includes collaborators AbbVie, Fürst Medical Laboratory, the Norwegian Institute of Public Health, and Oslo University.

According to its website, Age Labs applies machine learning techniques on large epigenetic datasets from Norwegian and international biobanks.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.